JOVAN MILOS: Open Payments
NPI 1366423295 · GLENDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 27 payments from 11 companies in 2025. Trend: 2023 $534 · 2024 $709 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Novo Nordisk Inc | 4 | $115 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Renalytix AI, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $50 |
| ABBVIE INC. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| PFIZER INC. | 1 | $22 |
Products named: FARXIGA, TRELEGY ELLIPTA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, Ozempic, VRAYLAR, JARDIANCE, AIRSUPRA, Rybelsus.
Industry payments across NY — which companies pay providers there.
